DIPENTUM Trademark

Trademark Overview


On Tuesday, October 30, 1984, a trademark application was filed for DIPENTUM with the United States Patent and Trademark Office. The USPTO has given the DIPENTUM trademark a serial number of 73506342. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, February 18, 2016. This trademark is owned by Pharmacia, Inc.. The DIPENTUM trademark is filed in the Pharmaceutical Products category with the following description:

a Medicinal Compound Used in the Treatment of Various Gastrointestinal [ and Rheumatoid ] Disorders
dipentum

General Information


Serial Number73506342
Word MarkDIPENTUM
Filing DateTuesday, October 30, 1984
Status800 - REGISTERED AND RENEWED
Status DateThursday, February 18, 2016
Registration Number1337522
Registration DateTuesday, May 28, 1985
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 19, 1985

Trademark Statements


Goods and Servicesa Medicinal Compound Used in the Treatment of Various Gastrointestinal [ and Rheumatoid ] Disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 19, 1985
Primary Code005
First Use Anywhere DateMonday, June 15, 1981
First Use In Commerce DateMonday, June 15, 1981

Trademark Owner History


Party NameALAVEN PHARMACEUTICAL, LLC
Party Type33 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressSomerset, NJ 088734120

Party NameUCB PHARMA LIMITED
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBERKSHIRE SL1 3WE
GB

Party NamePharmacia, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPiscataway, NJ 08854

Party NamePharmacia, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPiscataway, NJ 08854

Party NamePharmacia, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPiscataway, NJ 08854

Trademark Events


Event DateEvent Description
Wednesday, January 23, 1985EXAMINER'S AMENDMENT MAILED
Tuesday, January 15, 1985ASSIGNED TO EXAMINER
Thursday, January 24, 1985APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 9, 1985NOTICE OF PUBLICATION
Friday, March 8, 1985NOTICE OF PUBLICATION
Tuesday, March 19, 1985PUBLISHED FOR OPPOSITION
Tuesday, May 28, 1985REGISTERED-PRINCIPAL REGISTER
Tuesday, May 31, 2005REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Tuesday, July 24, 1990REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Monday, September 24, 1990REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, August 8, 2002PAPER RECEIVED
Tuesday, May 31, 2005PAPER RECEIVED
Wednesday, May 28, 2008CASE FILE IN TICRS
Wednesday, February 10, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, July 21, 2005ASSIGNED TO PARALEGAL
Thursday, December 8, 2005ASSIGNED TO PARALEGAL
Thursday, December 8, 2005REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, December 8, 2005REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, January 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 22, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 12, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, November 25, 2015TEAS SECTION 8 & 9 RECEIVED
Friday, February 3, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 28, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, February 3, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 18, 2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, February 18, 2016REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Thursday, February 18, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED